Stay updated on Adaptive TKI Therapy in Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Adaptive TKI Therapy in Thyroid Cancer Clinical Trial page.

Latest updates to the Adaptive TKI Therapy in Thyroid Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a site release update without changing the displayed study details.SummaryDifference0.0%

- Check12 days agoChange DetectedRevision v3.5.2 was added and revision v3.5.0 was removed.SummaryDifference0.0%

- Check26 days agoChange DetectedAdded Differentiated thyroid carcinoma and Medullary thyroid carcinoma as conditions on the page. Included a Resources link to the Genetic and Rare Diseases Information Center.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No visible changes to study details, eligibility criteria, or page content.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision: v3.4.2 was added and older notices, including the lapse in government funding message and Revision: v3.4.1, were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Adaptive TKI Therapy in Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adaptive TKI Therapy in Thyroid Cancer Clinical Trial page.